Expertise

Christoph Meissner advises national and international clients on M&A transactions, private equity and venture capital investments as well as on corporate law matters.

Vita

From September 2024 to March 2025 on secondment with Simpson Thacher & Bartlett in New York.

Christoph Meissner studied in Hamburg and Boston. He then worked in several international law firms while completing his doctorate. During his legal clerkship at the Higher Regional Court of Berlin he worked for the Federal Chancellery and the German American Chamber of Commerce in New York. He has been with Gleiss Lutz since 2019.

Christoph Meissner speaks German and English.

News
Gleiss Lutz advises Global Payments on a joint venture with Commerzbank Mandate
Gleiss Lutz advises NOVEC B.V. on the sale of its German telecom mast business to Phoenix Tower International Mandate
Gleiss Lutz advises Pitango on investment in digital health startup Patient21 Mandate
Gleiss Lutz advises Curaleaf on the acquisition of a majority stake and a strategic partnership with Four 20 Pharma Mandate
Gleiss Lutz advises Investindustrial on the acquisition of Aakamp Group by Farmaceutici Procemsa Mandate
Gleiss Lutz advises medical devices manufacturer Integer on its acquisition of Oscor Mandate

All news

Expertise

Christoph Meissner advises national and international clients on M&A transactions, private equity and venture capital investments as well as on corporate law matters.

Vita

From September 2024 to March 2025 on secondment with Simpson Thacher & Bartlett in New York.

Christoph Meissner studied in Hamburg and Boston. He then worked in several international law firms while completing his doctorate. During his legal clerkship at the Higher Regional Court of Berlin he worked for the Federal Chancellery and the German American Chamber of Commerce in New York. He has been with Gleiss Lutz since 2019.

Christoph Meissner speaks German and English.

News
Gleiss Lutz advises Global Payments on a joint venture with Commerzbank Mandate
Gleiss Lutz advises NOVEC B.V. on the sale of its German telecom mast business to Phoenix Tower International Mandate
Gleiss Lutz advises Pitango on investment in digital health startup Patient21 Mandate
Gleiss Lutz advises Curaleaf on the acquisition of a majority stake and a strategic partnership with Four 20 Pharma Mandate
Gleiss Lutz advises Investindustrial on the acquisition of Aakamp Group by Farmaceutici Procemsa Mandate
Gleiss Lutz advises medical devices manufacturer Integer on its acquisition of Oscor Mandate

All news